Concepedia

Nicole L. Kallewaard

NL

Statistics

Publications

16

Citations

3.3K

H-Index

14

Active since

2003

Affiliations

Vanderbilt University Medical Center(Current)

Eli Lilly (United States)

Vanderbilt University

AstraZeneca (United States)

Cedars-Sinai Medical Center

Nicole L. Kallewaard is an author at Vanderbilt University Medical Center specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2003–2022

16

Publications

16

Potently neutralizing and protective human antibodies against SARS-CoV-2

Seth J. Zost, Pavlo Gilchuk, James Brett Case et al. · Nature · 2020 · 1.2K citations · Full text

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 931 citations · Full text

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 208 citations · Full text

, , +18

Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus

Nicole L. Kallewaard, Amber L. Bowen, James E. Crowe · Virology · 2004 · 104 citations

, , +8

1–5 of 16